UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 12)*
DraftDay Fantasy Sports, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
261427108
(CUSIP Number)
Mitchell J. Nelson, 902 Broadway, 11th Floor, New York, NY  10010
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
06/03/2016
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g),
check the following box.
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See 240.13d-7 for other parties
to whom copies are to be sent.
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).





CUSIP No.  261427108

13D/A







1.
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS (ENTITIES ONLY)
Robert F.X. Sillerman

2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)
(b)


3.
SEC USE ONLY

4.
SOURCE OF FUNDS (see instructions)
PF


5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)

6.
CITIZENSHIP OR PLACE OF ORGANIZATION
USA






NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.
SOLE VOTING POWER
162,268



8.
SHARED VOTING POWER
42,049,331


9.
SOLE DISPOSITIVE POWER
162,268


10.
SHARED DISPOSITIVE POWER
42,049,331






11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
42,211,599


12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(see instructions)

13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
67.6%


14.
TYPE OF REPORTING PERSON (see instructions)
IN

CUSIP No. 261427108

13D/A






Item 1.Security and Issuer.
This Schedule 13D relates to the common stock, par value, $0.001 per share (the
"Common Stock"), of Function(x)Inc., a Delaware corporation (the "Company")
The address of the principal executive offices of the Company is 902 Broadway,
11th Floor, New York, NY  10010.  The Reporting Person filed Amendment No. 11
to this Schedule 13D on December 14, 2015.
Item 2.Identity and Background.
(a) The Reporting Person is Robert F.X. Sillerman.
(b) The Reporting Person's business address is 902 Broadway, 11th Floor,
New York, NY 10010.
(c) The Reporting Person is the Executive Chairman and Chief Executive
Officer of the Company.
(d) During the past five years, the reporting Person has not been convicted
in a criminal proceeding (excluding traffic violations or similar
misdemeanors).
(e) During the past five years, the Reporting Person has not been a party to a
civil proceeding of a judicial or administrative body of competent jurisdiction
pursuant to which as a result of such proceeding the reporting Person was or
is subject to a judgment, decree or final order enjoining future violations
of, or prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws.
(f) The Reporting Person is a citizen of the U.S.A.
Item 3.Source or Amount of Funds or Other Consideration.
Mr. Sillerman has used his personal funds to make purchases of the Company's
securities.
Item 4.Purpose of Transaction.
This Amendment No. 12 to Schedule 13D is filed to report a transaction pursuant
to which Sillerman Investment Company III LLC ("SIC III"), of which the
Reporting Person is the sole member and manager, acquired 22,580,645 shares
of the Company's Common Stock.

On October 24, 2014, the Company and SIC III entered into a Securities Purchase
Agreement (the "Securities Purchase Agreement") pursuant to which SIC III
agreed to purchase certain securities issued by the Company for a total
of $30,000,000. These securities included a Line of Credit Promissory Note
(the "Note") issued by the Company to SIC III. The Note provides for a
$20,000,000 line of credit to the Company. In addition, SIC III agreed
to purchase 10,000 shares of Series C Convertible Preferred Stock of the
Company for a total of $10,000,000. The terms of the Securities Purchase
Agreement are more fully described in Section 6 below. SIC III therefore
acquired 10,000 shares of the Company's Series C Convertible Preferred
Stock for $10,000,000.

On November 18, 2015, Viggle Inc. (the "Company") received a letter (the
"Letter") from the Listing Qualifications Department (the "Staff") of The
Nasdaq Stock Market ("NASDAQ") notifying the Company that the Staff has
determined that the Company violated the continuing listing requirements
of Nasdaq's Listing Rule 5550(b)(1). Listing Rule 5550(b)(1) requires that
companies listed on the NASDAQ Capital Market are required to maintain a
minimum of $2,500,000 in stockholders' equity for continued listing. The
Company's Quarterly Report on Form 10-Q for the period ended March 31, 2016
reported stockholders' equity of negative $28,635,000.  The Company requested
additional time to regain compliance, and presented a plan to the Nasdaq
Listing Qualifications Panel (the "Panel") to regain compliance.  The Panel
granted the Company's request.  The Company's continued listing on Nasdaq is
subject to, among other things, the Company evidencing compliance with the
minimum $2.5 million shareholder's equity requirement by August 22, 2016.


The Company and SIC III entered into a Subscription Agreement pursuant to which
SIC III subscribed for 22,580,645 shares of the Company's common stock at a
price of $0.31 per share. Accordingly, the aggregate purchase price for such
shares was $7,000,000.00.  The Company and SIC III agreed that SIC III would
pay the purchase price for such shares by exchanging 7,000 shares of the
Company's Series C Preferred Stock owned by SIC III for the common shares
(the "Exchange"). The effectiveness of the Exchange was subject to receipt
of an opinion by an independent valuation expert that the Exchange is fair
and confirmation by the Company's auditors that the Exchange will not lead to
a compensation charge, both of which the Company received.  The shares were
issued on June 3, 2016.

The Series C Preferred Shares were considered debt and not equity for purposes
of the Company's balance sheet.  Accordingly, the purchase of the shares of
Common Stock and corresponding reduction in the Company's debt will
enhance the Company's ability to regain compliance with the listing
requirements of the Nasdaq Capital Market.

The Reporting Person may enter into additional discussions with the Company
regarding transactions that may further facilitate the Company's compliance
with the minimum shareholder's equity requirement.

Item 5. Interest in Securities of the Issuer.
Item 5 of the Statement is hereby amended and restated as follows:
(a)
(b)
As of June 3, 2016, the Reporting Person is the beneficial owner of, and holds
the sole power to vote or to direct the vote and sole power to dispose or to
direct the disposition of 162,268 shares of Common Stock, and shared power to
vote or to dispose or to direct the disposition of 42,049,331 shares of Common
Stock.  Accordingly, that total of 42,211,599 represents approximately 67.6% of
the outstanding shares of Common Stock. These shares consist of:

30,811,268 shares of Common Stock held by Sillerman Investment Company III LLC
("SIC III"), of which the Reporting Person is the sole member and manager;


8,750,000 shares of Common Stock held by SIC IV, of which the Reporting Person
is the sole member and manager;


225,000 shares of Common Stock subject to warrants held by SIC III that are
exercisable at $3.51 per share;

150,000 shares of Common Stock subject to warrants held by SIC III that are
exercisable at $2.98 per share;


775,000 shares of Common Stock subject to warrants held by SIC III that are
exercisable at $3.63 per share;


350,000 shares of Common Stock subject to warrants held by SIC III that are
exercisable at $1.78 per share;


750,000 shares of Common Stock issuable as of December 3, 2015 upon the
conversion of 3,000 shares of Series C Convertible Preferred
Stock held by SIC III;

37,268 shares of Common Stock held directly by Mr. Sillerman;

125,000 shares of Common Stock subject to warrants held by Mr. Sillerman
that are exercisable at $80.00 per share.


62,500 shares of Common Stock subject to warrants held by Sillerman
Investment Company II, LLC ("SIC II"), of which Mr. Sillerman is the sole
member and manager, which warrants are exercisable at $55.20 per share; and

175,562.5 shares of Common Stock subject to warrants held by SIC II that are
 exercisable at $80.00 per share.
The percentage of the outstanding shares set forth above was calculated based
on 59,810,045 shares of Common Stock outstanding as of June 8, 2016.
Except as set forth above, as of June 8, 2016, the Reporting Person has not
effected any transactions in the shares of Common Stock during the past 60 days.

(d)
None.

(e)
Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
Securities Purchase Agreement

On October 24, 2014, the Company and SIC III entered into a Securities Purchase
Agreement (the "Securities Purchase Agreement") pursuant to which SIC III
agreed to purchase certain securities issued by the Company for a total of
$30,000,000. These securities included a Line of Credit Promissory Note (the
"Note") issued by the Company to SIC III. The Note provides for a $20,000,000
line of credit to the Company. In addition, SIC III agreed to purchase 10,000
shares of Series C Convertible Preferred Stock of the Company for a total of
$10,000,000. The Company also agreed to issue to SIC III warrants to purchase
1,500,000 shares of Common Stock, with warrants to purchase 50,000 shares
of Common Stock to be issued for every $1,000,000 the Company draws under
the Note and every $1,000,000 paid by SIC III for shares of Series C
Convertible Preferred Stock. The exercise price of the warrants was to be 10%
above the closing price of the shares of the Common Stock on the date prior
to the issuance of the applicable warrants. Exercise of the warrants was
subject to approval of the Company's stockholders, which the Company
obtained on January 13, 2015, at the Company's 2015 Annual Meeting of
Stockholders.

The foregoing summary of the Securities Purchase Agreement does not purport to
be complete and is subject to, and qualified in its entirety by, the full text
of the Securities Purchase Agreement, which is attached as Exhibit 3.1 and
incorporated herein by reference.

Line of Credit Note

On October 24, 2014, the Company issued the Note to SIC III. The Note provides
a right on the part of the Company to request advances under the Note from time
to time. On October 24, 2014, SIC III made an initial advance under the Note of
$4,500,000. On December 14, 2014, SIC III made an additional advance under the
Note in the amount of $15,500,000. As of March 19, 2015, the outstanding
principal amount of the Note is $20,000,000.

The Note bears interest at a rate of 12% per annum, payable in cash on a
quarterly basis. In addition, the Note provides for a 3% discount, such that
the amount advanced by SIC III was 3% less than the associated principal
amount of the advance. From and after the occurrence and during the continuance
of any event of default under the Note, the interest rate is automatically
increased to 17% per annum.

The Note is not convertible into equity securities of the Company.

If an event of default occurs under the Note, SIC III has the right to require
the Company to repay all or any portion of the Note. Events of default under
the Note include payment defaults, and certain bankruptcy-type events involving
the Company. The Company may, at its option, prepay the Note, in whole or in
part. If the Company chooses to prepay the Note, it is required to prepay a
fixed lump sum in the amount of 106% of the principal amount then being
prepaid, plus interest accrued thereon. In the event that the Company issues
primary shares in a public offering at an offering price above $5.00 per share,
the Company may use up to 33% of the proceeds to prepay the Note at par plus
accrued and unpaid interest. Upon the occurrences of certain changes of
control, SIC III has the right to require the Company to repay the entire
amount of the Note on the prepayment terms set forth above.

The Note also contains certain covenants and restrictions, including, among
others, that, for so long as the Note is outstanding, the Company will not,
without the consent of the holder of the Note, (i) make any loan or advance
in excess of $500,000 to any officer, director, employee of affiliate of the
Company (except advances and similar expenditures: (a) under the terms of
employee stock or option plans approved by the Board of Directors, (b) in the
ordinary course of business, consistent with past practice or (c) to its
subsidiaries), (ii) incur any indebtedness that exceeds $1,000,000 in the
aggregate other than indebtedness outstanding under the Note, (iii) guaranty
any indebtedness of any unaffiliated third party, (iv) change the principal
business of the Company or exit the Company's current business, provided that
the foregoing is subject to the Board's compliance with its fiduciary duties,
(v) sell, assign, or license material technology or intellectual property of
the Company except (a) in the ordinary course of business, consistent with
past practice, (b) sales and assignments thereof in any 12 month period that
do not have a fair market value in excess of $500,000 or (c) in connection
with a change of control transaction, (vi) enter into any corporate
strategic relationship involving the payment, contribution or assignment
by the Company of its assets that have a fair market value in excess of
$1,000,000 or (vii) liquidate or dissolve the Company or wind up the
business of the Company, except in connection with changes of control
or merger, acquisition or similar transactions or as approved by the
Company's Board in compliance with their fiduciary duties.

The foregoing description of the Note is not complete and is subject to and
qualified in its entirety by reference to the Note, which is attached as
Exhibit 3.2 and incorporated herein by reference

Series C Convertible Preferred Stock

On November 25, 2014, pursuant to the Securities Purchase Agreement described
above, SIC III purchased from the Company 3,000 shares of Series C Convertible
Preferred Stock of the Company for $3,000,000. In addition, on March 16,
2015, SIC III purchased 7,000 shares of Series C Convertible Preferred Stock
pursuant to the Securities Purchase Agreement for a purchase price of
 $7,000,000.

The shares of Series C Convertible Preferred Stock have a stated value
of $1,000 per share (the "Stated Value").

Each share of Series C Convertible Preferred Stock entitles its holder to
receive dividends ("Dividends") on such share equal to 12% per annum (the
"Dividend Rate") of the Stated Value before any Dividends shall be declared,
set apart for or paid upon any junior stock or parity stock. Dividends on a
share of Series C Convertible Preferred Stock accrue daily at the Dividend R
ate, compound annually, are computed on the basis of a 360-day year
consisting of twelve 30-day months and are convertible into shares of
Common Stock in connection with the conversion of such share of Series C
Convertible Preferred Stock.

Each share of Series C Convertible Preferred Stock is convertible, at the
option of the holders, on the basis of its Stated Value and accrued, but unpaid
Dividends, into shares of Common Stock at a conversion price of $4.00 per share
of Common Stock.

The Company may redeem any or all of the outstanding shares of Series C
Convertible Preferred Stock at any time at the then current Stated Value plus
accrued Dividends thereon plus a redemption premium equal to the Stated Value
multiplied by 6%. However, no premium will be due to the extent the redemption
of shares of Series C Convertible Preferred Stock uses up to 33% of proceeds
of a public offering of shares of Common Stock at a price of $5.00 or more
per share.

The Company is required to redeem all outstanding shares of Series C
Convertible Preferred Stock on the tenth (10th) business day immediately
following the fifth anniversary of its issuance. However, the Company will
have no obligation to mandatorily redeem any shares of Series C Convertible
Preferred Stock at any time that (x) the Company does not have surplus under
Section 154 of the Delaware General Corporation Law (the "DGCL") or funds
legally available to redeem all shares of Series C Convertible Preferred Stock,
(y) the Company's capital is impaired under Section 160 of the DGCL or (z)
the redemption of any shares of Series C Convertible Preferred Stock
would result in an impairment of the Company's capital under Section
160 of the DGCL; provided, that if the Company is prohibited from redeeming
the shares of Series C Convertible Preferred Stock on due to those limitations,
the Company will be obligated to redeem the shares of Series C Convertible
Preferred Stock as soon as possible after such restrictions are no longer
applicable.

Upon a change of control of the Company, each holder of shares of Series C
Convertible Preferred Stock will be entitled to require the Company to redeem
from such holder all of such holder's shares of Series C Convertible Preferred
Stock so long as such holder requests such redemption in writing at least
one (1) business day prior to the consummation of such change of control. The
redemption amount per share equals the Stated Value thereof plus accrued
Dividends plus a change of control premium equal to the Stated Value multiplied
by 6%.

The shares of Series C Convertible Preferred Stock are senior in liquidation
preference to all shares of capital stock of the Company unless otherwise
consented to by a majority of the holders of shares of Series C Convertible
Preferred Stock.

The shares of Series C Convertible Preferred Stock have no voting rights except
as required by law.

The consent of the holders of a majority of the shares of Series C Convertible
Preferred Stock is necessary for the Company to amend the Series C Certificate
of Designation for the shares of Series C Convertible Preferred Stock were
issued.

The foregoing summary of the Series C Convertible Preferred Stock does not
purport to be complete and is subject to, and qualified in its entirety by,
the full text of the Certificate of Designation for the shares of Series C
Convertible Preferred Stock, which is attached as Exhibit 3.3 and incorporated
herein by reference.

Warrants

On October 24, 2014, in connection with the first drawdown of $4,500,000
under the Note, the Company issued to SIC III warrants to purchase 225,000
shares of the Company's common stock. These warrants have an exercise
price of $3.51. On November 25, 2014, in connection with SIC III's purchase
of 3,000 shares of Series C Convertible Preferred Stock, the Company issued
to SIC III warrants to purchase 150,000 shares of Common Stock at an
exercise price of $2.98 per share. On December 15, 2014, in connection with
an advance of $15,500,000 under the Note, the Company issued to SIC III
warrants to purchase 775,000 shares of Common Stock at an exercise price of
$3.63 per share. On March 16, 2015, in connection with SIC III's purchase of
7,000 shares of Series C Convertible Preferred Stock, the Company issued to
SIC III warrants to purchase 350,000 shares of the Company's Common Stock
at an exercise price of $1.78 per share. Each of the warrants is exercisable
for a period of ten (10) years from its date of issuance.

The foregoing summary of the warrants does not purport to be complete and is
subject to, and qualified in its entirety by, the full text of the form of
warrant, which is attached as Exhibit 3.4 and incorporated herein by reference.

Registration Rights Agreement

On October 24, 2014, the Company entered into a Registration Rights
Agreement (the "Registration Rights Agreement") with SIC III pursuant to
which the Company agreed to register the shares of the Company's capital
stock owned by SIC III. The Registration Rights Agreement allows SIC III to
require the Company to register its shares. If the Company receives such a
request from SIC III, the Company will use its best efforts to effect such
registration. In addition, if the Company otherwise initiates a registration
of shares of its capital stock (other than pursuant to a Registration
Statement on Form S-4 or S-8, or any successor forms), SIC III will have a
right to participate in such registration, subject to cutbacks set by the
underwriter in such registration.

The foregoing summary of the Registration Rights Agreement does not purport
to be complete and is subject to, and qualified in its entirety by, the full
text of the Registration Rights Agreement, which is attached as Exhibit
3.5 and incorporated herein by reference.

Options and Restricted Stock Units

Mr. Sillerman holds 37,268 shares of Common Stock that were issuable upon
the vesting of restricted stock units.

Mr. Sillerman holds restricted stock units in respect of 124,072 shares of
Common Stock granted pursuant to Company's 2011 Executive Incentive
Plan. These restricted stock units vested as to 31,018 shares on May 1,
2015, and will vest as to 31,018 shares on each of May 1, 2016, May 1,
2017, May 1, 2018 and May 1, 2019.

The foregoing description of the restricted stock units held by Mr. Sillerman
is not complete and is qualified in its entirety by reference to the full text
of the 2011 Executive Incentive Plan, which is attached as Exhibit 3.6 and
incorporated herein by reference.

Warrants held by SIC II

SIC II holds warrants to purchase 62,500 shares of Common Stock at an
exercise price of $55.20 per share. The warrants are exercisable until
September 16, 2018.

SIC II also holds warrants to purchase 175,562.5 shares of Common Stock at
an exercise price of $80.00 per share. The warrants are exercisable until
various dates in 2018.

The foregoing description of the warrants held by SIC II is not complete and is
qualified in its entirety by reference to the full text of the form of the
warrant, which is attached as Exhibit 3.7 and incorporated herein by reference.

Subscription Agreement

SIC IV agreed to provide a Line of Credit to the Company of up to $10,000,000
(the "Line of Credit"). As of December 3, 2015, there was $8,675,000 in
outstanding principal amount under the Line of Credit.  On December 3, 2015,
the Company and SIC IV entered into a Subscription Agreement pursuant to
which SIC IV subscribed for 8,750,000 shares of the Company's common
stock at a price of $0.47 per share. Accordingly, the aggregate purchase price
for such shares was $4,112,500.00. The Company and SIC IV agreed
that SIC IV would pay the purchase price for such shares by reducing the
amounts outstanding under the Line of Credit. Accordingly, the principal
amount of the Line of Credit was reduced to $4,562,500.00.

The foregoing description of the Subscription Agreement and the transactions
contemplated thereby are not complete and are subject to, and qualified in
their entirety by, reference to the form of the Subscription Agreement attached
hereto as Exhibit 3.8 and incorporated therein by reference.

Additional Subscription Agreement

The Company and SIC III entered into a Subscription Agreement, dated as of
May 9, 2016 (the "May Subscription Agreement") pursuant to which SIC III
subscribed for 22,580,645 shares of the Company's common stock at a price
of $0.31 per share. Accordingly, the aggregate purchase price for such
shares was $7,000,000.00.  The Company and SIC III agreed that SIC III
would pay the purchase price for such shares by exchanging 7,000 shares
of the Company's Series C Preferred Stock owned by SIC III for the common
shares (the "Exchange").  The effectiveness of the Exchange was subject
to receipt of an opinion by an independent valuation expert that the
Exchange is fair and confirmation by the Company's auditors that the
Exchange will not lead to a compensation charge, both of which the
Company received.

The foregoing description of the May Subscription Agreement and the
transactions contemplated thereby are not complete and are subject to,
and qualified in their entirety by, reference to the form of the May
Subscription Agreement attached hereto as Exhibit 3.9 and incorporated
therein by reference.Item 7. Material to Be Filed as Exhibits.
Exhibit 3.1

 Securities Purchase Agreement, dated as of October 24, 2014,
by and between the Company and Sillerman Investment Company III LLC
(incorporated by reference to Exhibit 10.1 to the Current Report on Form
8-K filed by the Company on October 27, 2014)
Exhibit 3.2

Line of Credit Promissory Note, dated as of October 24, 2014,
issued by the Company in favor of Sillerman Investment Company III LLC
(incorporated by reference to Exhibit 10.2 to the Current Report on Form
8-K filed by the Company on October 27, 2014)
Exhibit 3.3

 Certificate of Designations of the Series C Convertible
Preferred Stock (incorporated by reference to Exhibit 3.1 to the Current
Report on Form 8-K filed by the Company on October 27, 2014)
Exhibit 3.4

 Form of Warrant issuable pursuant to the Securities
Purchase Agreement (incorporated by reference to Exhibit 10.3 to the
Current Report on Form 8-K filed by the Company on October 27, 2014)


Exhibit 3.5

 Registration Rights Agreement, dated as of October 24, 2014,
by and between the Company and Sillerman Investment Company III LLC
(incorporated by reference to Exhibit 10.4 to the Current Report on
Form 8-K filed by the Company on October 27, 2014)


Exhibit 3.6

 2011 Executive Incentive Plan (incorporated by reference
to Exhibit B to the Company's Amended Information Statement on Form
14C filed by the Company on June 15, 2015)

Exhibit 3.7

Form of Warrant (incorporated by reference to Exhibit
10.2 to the Current Report on Form 8-K filed by the Company on March
15, 2013)

Exhibit 3.8
 Subscription Agreement, dated as of December 3, 2015,
by and between the Company and Sillerman Investment Company IV LLC
(incorporated by reference to Exhibit 10.1 to the Current Report on
Form 8-K filed by the Company on December 7, 2015)



Exhibit 3.9
 Subscription Agreement, dated as of March 9, 2016, by
and between the Company and Sillerman Investment Company III LLC
(incorporated by reference to Exhibit 10.1 to the Current Report on
Form 8-K filed by the Company on May 13, 2016)





CUSIP No. 261427108
13D/A



SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.
FUNCTION(X) INC.

/s/ Robert F.X. Sillerman
Insert Name


Insert Title

June 8, 2016
Insert Date



INDEX TO EXHIBITS
Exhibit 3.1

 Securities Purchase Agreement, dated as of October 24, 2014,
by and between the Company and Sillerman Investment Company III LLC
(incorporated by reference to Exhibit 10.1 to the Current Report on Form
8-K filed by the Company on October 27, 2014)
Exhibit 3.2

Line of Credit Promissory Note, dated as of October 24, 2014,
issued by the Company in favor of Sillerman Investment Company III LLC
(incorporated by reference to Exhibit 10.2 to the Current Report on Form
8-K filed by the Company on October 27, 2014)


Exhibit 3.3

 Certificate of Designations of the Series C Convertible
Preferred Stock (incorporated by reference to Exhibit 3.1 to the Current
Report on Form 8-K filed by the Company on October 27, 2014)
Exhibit 3.4

 Form of Warrant issuable pursuant to the Securities
Purchase Agreement (incorporated by reference to Exhibit 10.3 to the
Current Report on Form 8-K filed by the Company on October 27, 2014)
Exhibit 3.5

 Registration Rights Agreement, dated as of October 24, 2014,
by and between the Company and Sillerman Investment Company III LLC
(incorporated by reference to Exhibit 10.4 to the Current Report on
Form 8-K filed by the Company on October 27, 2014)
Exhibit 3.6

 2011 Executive Incentive Plan (incorporated by reference
to Exhibit B to the Company's Amended Information Statement on Form
14C filed by the Company on June 15, 2015)
Exhibit 3.7

Form of Warrant (incorporated by reference to Exhibit
10.2 to the Current Report on Form 8-K filed by the Company on March
15, 2013)
Exhibit 3.8
 Subscription Agreement, dated as of December 3, 2015,
by and between the Company and Sillerman Investment Company IV LLC
(incorporated by reference to Exhibit 10.1 to the Current Report on
Form 8-K filed by the Company on December 7, 2015)
Exhibit 3.9
 Subscription Agreement, dated as of March 9, 2016, by
and between the Company and Sillerman Investment Company III LLC
(incorporated by reference to Exhibit 10.1 to the Current Report on
Form 8-K filed by the Company on May 13, 2016)